Grant: Operating Grant - Priority Announcement: Aging (Bridge Funding)
University of Toronto
$100,000.00
Splice variant and paralog specific analysis of the gamma secretase - amyloid precursor protein complexome
EF 2008-09
Résumé
A key event in the molecular manifestation of Alzheimer disease is the aberrant proteolytic cleavage of the amyloid precursor protein (APP) by a multi-protein enzyme complex referred to as gamma-secretase. Attempts to devise a therapeutic strategy that targets gamma-secretase complexes have proven difficult because the substrate specificity and molecular architecture of a heterogeneous population of gamma-secretase complexes is only poorly understood. We have developed crosslinking methodologies that enable identification of protein complex constituents and facilitate topological characterization of protein complexes. We propose to apply these methods to the gamma-secretase-APP complexome to uncover a feature of APP processing that can be exploited to derive an effective therapeutic strategy.
Programme
Operating Grant - Priority Announcement: Aging (Bridge Funding)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
176204
Name
Schmitt-Ulms Gerold
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Molecular & Cellular Neurosciences - B
Projecttitle
Splice variant and paralog specific analysis of the gamma secretase - amyloid precursor protein complexome
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Aging (Bridge Funding)
Keyworddelim
Alzheimer Disease; Chemical Crosslinking; Complexome; Lentiviral Technology; Mass Spectrometry; Protein-Protein Interactions
Abstract
A key event in the molecular manifestation of Alzheimer disease is the aberrant proteolytic cleavage of the amyloid precursor protein (APP) by a multi-protein enzyme complex referred to as gamma-secretase. Attempts to devise a therapeutic strategy that targets gamma-secretase complexes have proven difficult because the substrate specificity and molecular architecture of a heterogeneous population of gamma-secretase complexes is only poorly understood. We have developed crosslinking methodologies that enable identification of protein complex constituents and facilitate topological characterization of protein complexes. We propose to apply these methods to the gamma-secretase-APP complexome to uncover a feature of APP processing that can be exploited to derive an effective therapeutic strategy.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Schmitt-Ulms, Gerold
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~